Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.07%
#3 Glidr Glidr +36.87%
#4 CoW Protocol CoW Protocol +36.76%
#5 Humanity Humanity +25.32%
#6 Enso Enso +23.07%
#7 Walrus Walrus +22.73%
#8 Tutorial Tutorial +19.23%
#9 Codatta Codatta +16.99%
#10 Versatize Coin Versatize Coin +12.49%
Coin of the day
EXOD EXOD
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Carmell Therapeutics Corporation Carmell Therapeutics Corporation

Carmell Therapeutics Corporation

CTCX
Clasificación en acciones #36666
Carmell Therapeutics Corporation (CTCX) specializes in the creation of... Carmell Therapeutics Corporation (CTCX) specializes in the creation of plasma-based bioactive materials (PBMs) aimed at catalyzing tissue regeneration and repair following injury, illness, or the effects of aging. Their flagship product, CT-101, is a versatile accelerant with a dual focus. For orthopedic and dental applications, it's designed to enhance bone healing in cases such as tibia fractures, foot and ankle fusions, spinal fusions, and also serves as a dental bone graft substitute and bone void filler. Furthermore, CT-101 acts as a tissue healing accelerant, addressing conditions like androgenetic alopecia (pattern baldness) and persistent chronic wounds. Established in 2008, the company operates from its headquarters in Pittsburgh, Pennsylvania.
Precio por acción
$0.117
Última sincronización: 2025-04-04
Capitalización bursátil
$2.45M
Cambio (1 día)
-13.59%
Cambio (1 año)
0.00%
País
US
Comercio Carmell Therapeutics Corporation (CTCX)

Categoría

Healthcare
EPS de Carmell Therapeutics Corporation (CTCX)
EPS a fecha de June 2026 TTM: $-4.71
Según los últimos informes financieros y el precio de las acciones de Carmell Therapeutics Corporation, el EPS actual de la empresa (TTM) es $-4.71. Al final del año 2023, la empresa tenía un EPS de $-0.74 un aumento con respecto a al EPS de 2022, que fue de $-0.50.
Historial de EPS de Carmell Therapeutics Corporation desde 2021 hasta 2026
EPS al final de cada año
Año EPS Cambiar
2026 (TTM) $-4.71 842.00%
2024 $-0.50 -32.43%
2023 $-0.74 48.00%
2022 $-0.50 4,487.16%
2021 $-0.01 0.00%
EPS de empresas similares o competidoras
Empresa EPS Diferencia de EPS País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -467.73%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -688.96%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -390.87%
BE